PGNY250117C55000
- 0.75
- 0.000.00%
Progyny Newsroom
Progyny Pick of the Week at Smart Insider Following CEO, Executive Chair Stock Purchases
Insider Spends US$3.0m Buying More Shares In Progyny
Progyny Up Over 11%, on Pace for Largest Percent Increase Since February 2023 -- Data Talk
Progyny, Inc. (PGNY): A Bull Case Theory
Progyny up 6% on Insider Buys
Progyny(PGNY.US) Officer Buys US$3.03 Million in Common Stock
$Progyny(PGNY.US)$ Officer Anevski Peter purchased 209.5K shares of common stock on Dec 23, 2024 at an average price of $14.4825 for a total value of $3.03 million.Source: Announcement What is
Progyny CEO Peter Anevski Buys $3 Million in Shares
Is Now The Time To Look At Buying Progyny, Inc. (NASDAQ:PGNY)?
Progyny Price Target Cut to $17.00/Share From $22.00 by JP Morgan
J.P. Morgan Downgrades Progyny(PGNY.US) to Hold Rating, Announces Target Price $17
Progyny's Short-Term Challenges and Long-Term Promise: A Hold Rating Amidst Market Pressures
Express News | Progyny Inc : JP Morgan Cuts to Neutral From Overweight
Meridian Hedged Equity Fund Decided to Sell Its Holdings in Progyny (PGNY). Here's Why
Progyny (NASDAQ:PGNY) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Rallies 11% This Past Week
Here's Why Progyny (PGNY) Was Under Pressure in Q3
Health Care Roundup: Market Talk
Progyny Is Maintained at Overweight by Barclays
Progyny, Inc. to Present at Jefferies London Healthcare Conference
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $17 to $22
Progyny Price Target Lowered to $21 From $22 at BofA